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SulfatideCobra CTX A3, the major cardiotoxin (CTX) from Naja atra, is a cytotoxic, basic β-sheet polypeptide that is
known to induce a transient membrane leakage of cardiomyocytes through a sulfatide-dependent CTX
membrane pore formation and internalization mechanism. The molecular speciﬁcity of CTX A3-sulfatide
interaction at atomic levels has also been shown by both nuclear magnetic resonance (NMR) and X-ray dif-
fraction techniques to reveal a role of CTX-induced sulfatide conformational changes for CTX A3 binding and
dimer formation. In this study, we investigate the role of sulfatide lipid domains in CTX pore formation by
various biophysical methods, including ﬂuorescence imaging and atomic force microscopy, and suggest an
important role of liquid-disordered (ld) and solid-ordered (so) phase boundary in lipid domains to facilitate
the process. Fluorescence spectroscopic studies on the kinetics of membrane leakage and CTX oligomeriza-
tion further reveal that, although most CTXs can oligomerize on membranes, only a small fraction of CTXs
oligomerizations form leakage pores. We therefore suggest that CTX binding at the boundary between the
so and so/ld phase coexistence sulfatide lipid domains could form effective pores to signiﬁcantly enhance
the CTX-induced membrane leakage of sulfatide-containing phosphatidylcholine vesicles. The model is con-
sistent with our earlier observations that CTX may penetrate and lyse the bilayers into small aggregates at a
lipid/protein molar ratio of about 20 in the ripple Pβ′ phase of phosphatidylcholine bilayers and suggest a
novel mechanism for the synergistic action of cobra secretary phospholipase A2 and CTXs.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Sphingolipids are ubiquitous constituents of all mammalian plas-
ma membranes. A diverse array of pathogens and protein toxins are
known to target sphingolipids [1–3]. For example, the ganglioside
GM1, globo-triaosylceramide, and globo-tetraosylceramide have
been shown to be the receptor for the cholera toxin from Vibrio cholera
[4], shiga toxin from Escherichia coli and the pig edemadisease toxin, re-
spectively [5]. Interestingly, in additional to the lipid binding speciﬁcity,
the formations of sphingolipid domains, or the so-called lipid rafts, have
also been suggested to signiﬁcantly modulate important biological ac-
tivities [6]. Thus, δ-lysin, a secreted peptide from Staphylococcus aureus,
preferentially binds to liquid-disordered (ld) domains, which concen-
trates the toxin and leads to dye efﬂux from lipid vesicles [7]. Melittin,echnology, Yuanpei University,
l.: +886 03 5381183x8160;
Science, National Tsing Hua
30013, Taiwan. Tel.: +886 3
. Huang),
l rights reserved.a toxin frombee venom, increasesmembrane leakage of sphingomyelin
containing vesicles because it forms transmembrane pores when the
solid-ordered (so) and liquid-disordered (ld) phase, i.e., so/ld phase, co-
exist [8]. The membrane binding afﬁnity of sea anemone-derived equi-
natoxin II is also strongly enhanced by the presence of sphingomyelin
and forms pores only under the liquid-ordered (lo)/ld coexistence
phase [9]. How the existence of sphingolipid domains could modulate
biological activities of pore formation toxins in the plasma membrane
is of current biophysical interests [10–13].
Cobra cardiotoxins (CTXs) are 60–62 amino acid amphiphilic
polypeptides consisting of extended β-sheets with a three-ﬁngered
loop folding topology [14]. CTXs are water-soluble proteins and
have strong binding afﬁnities on negatively charged membrane [15].
In vivo, CTXs cause systolic heart arrest, severe tissue necrosis, and/
or blindness [16]. In vitro, CTXs cause general cytotoxicity in many
cell types such as bacterial cells, human erythrocytes, cancer cells,
and cardiomyocytes [17–20]. Although other membrane targets
such as glycosaminoglycans or integrins have been shown to bind
to distinct type of CTXs and modulate CTX activities [21–25], the
lipid binding ability of CTXs, followed by their pore forming activity,
is believed to play important roles in the CTX-induced toxicity. As a
membrane acting toxin, CTXs induce membrane aggregation, fusion,
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named as cytotoxins [14]. However, recent studies on the action of
CTX A3 (a major CTX from Taiwan cobra venom) on cardiomyocytes
have suggested sulfatide as its speciﬁc target. Monoclonal antibodies
raised against sulfatide (sulfogalactosylceramide, SGC) are capable
of inhibiting the action of CTX A3 to prevent membrane leakage and
cell internalization [29,30]. CTX A3 forms pores speciﬁcally in
sulfatide-containing vesicles with pore sizes and lifetimes in the
range of about 30 Å and 10−2 s, respectively [31]. The crystal structure
of the CTXA3/sulfatide complex reveals an unexpected orientation for
the sulfatide fatty chains and sheds light on a possible mechanism of
lipid-mediated toxin translocation [32]. Since sulfatides exist in the
outer leaﬂet of most eukaryotic plasma membranes including male
germ cells, myelin sheath cells, and epithelial cells [33] and have been
classiﬁed as a component of lipid rafts [34,35], it is interesting to
know whether sulfatide lipid domains are also involved in its pore
forming activity.
In this study, we investigate the role of sulfatide lipid domains in
CTX pore formation by various biophysical methods, including ﬂuo-
rescence imaging and atomic force microscopy. A phase diagram of
sulfatide/1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC)
mixture is also presented and correlated with CTX-induced mem-
brane leakage activity. By comparing how phosphatidylserine (PS)-
and sulfatides-containing membranes could differentially modulate
the oligomerization process of CTXs and their related membrane
leakage activity, we demonstrate the existence of sulfatide lipid do-
mains and its important role in regulating CTX pore formation. The
results suggest that effective CTX pore formation followed by CTX
oligomerization only occurs at the sulfatide lipid domain boundary.
Since secretary phospholipase A2 is also ubiquitously present in
cobra venom and has been shown recently to restructure membranes
in the presence of lipid domains [11], a novel mechanism is proposed
to explain the synergistic action between phospholipase A2 and CTXs.
2. Materials and methods
2.1. Materials and puriﬁcation
All lipids, 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine/sodiumsalt (POPS),
and sulfatides/porcine brain/ammonium salt were obtained com-
mercially from Avanti Polar Lipids (Alabaster, AL). Cholesterol, 6-
carboxyﬂuoresein (CF), rhodamine B isothiocyanate and 1,6-diphenyl-
1,3,5-hexatriene (DPH) were purchased from Sigma Aldrich (St. Louis,
MO). 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate
(DiIC18)was purchased from Invitrogen (U.S.A.). CTXA3 and rhodamine-
labeled CTX A3 (Rh-A3) were puriﬁed and conjugated as previously de-
scribed [31]. Brieﬂy, CTX A3 was puriﬁed by applying crude venoms
(from Snake Education Farm, Tainan, Taiwan) to a SP-Sephadex C-25
ion exchange column chromatograph followed by HPLC on a reverse-
phase C-18 column. The purity of all toxins was veriﬁed by SDS-PAGE,
HPLC and mass spectrometry.
2.2. Membrane vesicle leakage assay and CTX oligomerizationmeasurement
For leakage assays, lipidswere dried under nitrogen gas and vacuum
and then hydrated with 10 mM Tris (pH 7.4) containing 75 mM NaCl
and 50 mM CF. Lipid mixtures were extruded through polycarbonate
ﬁlters (pore size 0.1 μm) to obtain homogeneous large unilamellar
vesicles (LUVs). The residual ﬂuorescence molecules on the outside
of the vesicles were removed using a Sepharose CL-4B column with
10 mM Tris (pH 7.4), 150 mM NaCl buffer solution. The CF leakage
was calculated using the following expression: leakage=(Ft−Fi)/
(Ff−Fi), where Fi is the initial ﬂuorescence before adding proteins,
Ft is the ﬂuorescence reading at time t, and Ff is the ﬁnal ﬂuorescencedetermined by adding 0.02% Triton X-100 [36]. Fluorescence was ex-
cited at 480 nm and emitted at 520 nm.
For evaluation of temperature effect on leakage, the cuvette in-
cluding vesicle solutions was ﬁrst incubated at the desired tempera-
ture by a circulating water system for 10 min and then the desired
amount of CTX A3 was added. The temperatures were monitored di-
rectly inside the cuvette with a thermocouple thermometer. Different
samples were used for each temperature measuring experiment.
For oligomerization assays, LUVs were prepared with a 10 mM Tris
(pH 7.4), 150 mM NaCl buffer solution without going through the
procedure with the CL-4B column puriﬁcation. Varying concentra-
tions of Rh-A3 were added to the vesicle solution (10 μM) and the
ability of CTX A3 to oligomerize is monitored by ﬂuorescence reso-
nance energy transfer between identical probes (homo-FRET) by ex-
citing and emitting at 550 nm and 580 nm, respectively.2.3. Monolayer penetration
Monolayer experiments were done on a Langmuir minitrough
(Joyce-Laebl Ltd.) as previously reported [26]. Brieﬂy, surface pressure
was determined in a ﬁxed-area, circular Petri dish. The measurements
were carried out at the desired temperature and under constant stirring.
Lipid mixtures, dissolved in a methanol/chloroform solution, were gent-
ly spread onto the air/water interface in the trough and the amounts of
lipid mixture were controlled to obtain the desired initial pressure. The
subphase solution was prepared in the same manner as the LUVs. The
desired amount of CTX A3 (50 nM) was then added for CTX penetration
measurement.2.4. Phase diagram determination of sulfatide/POPC dispersions
The ﬂuorescence anisotropy measurements were carried out on an
SLM-4800 spectroﬂuorometer. The phase diagram for sulfatide/POPC
multilamellar vesicles was determined according to Rodrigo F. M. et
al. [37]. Brieﬂy, a molar ratio of 0.1% DPH was used as the probe for
theﬂuorescence anisotropymeasurements. TheDPH containing sample
was excited at 360 nm, and the emitted wavelength was recorded at
431 nm. The recorded intensities were used to compute the ﬂuores-
cence anisotropy br> according to the equation of br>=(I∥− I⊥)/
(I∥+2I⊥), where I∥ and I⊥ represent the polarized ﬂuorescence intensity
in parallel and perpendicular directions, respectively.2.5. Fluorescence imaging microscopy
Theﬂuorescence imagingwas performed as previously described [38].
Brieﬂy, the experiments were performed in a home-built, wide-ﬁeld ge-
ometry inverted microscope (Olympus IX70; 100× objective). Light
from a continuous-wave diode-pumped YAG laser was used to excite at
532 nm and ﬂuorescence images were recorded by an electron multiply-
ing charge-coupled device (EMCCD; Andor Ixon DV-887BI). Andor Solis
was used for image acquisition and storage.2.6. Atomic force microscopy
Supported bilayers were prepared from small unilamellar vesicles
(SUV) on mica by the calcium chloride fusion method [39]. Lipid ﬁlms
were dried under vacuum for at least 16 h and then hydrated with
buffer containing 10 mM Tris–HCl (pH 7.4) and 150 mM NaCl. After
sonication, supported bilayers were prepared by fusion of SUVs
(~1 mM) with 10 mM calcium chloride on mica for 1 h. AFM mea-
surements for bilayer samples were carried out on a Picoscan atomic
force microscope (Molecular Imaging, MI) in Mac mode with Type II
MAClevers (62-014; Molecular Imaging) at 25 °C.
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3.1. CTX-induced membrane leakage on sulfatides or POPS containing
POPC large unilamellar vesicles
We have previously shown by ﬂuorescence spectroscopic mea-
surement on the membrane pore forming activities by comparing
the retention ratio between ﬂuorescence probe with different molecu-
lar weight such as dextran probe of FD-70 and FD-4 and concluded
that the CTX A3-induce pore in sulfatide containing vesicles is
~25–30 Å diameter [31]. The CTX A3 pores in sulfatide containing
POPC vesicles are similar to the CTX A3 pores observed in cardiomyo-
cyte membranes. But, it is more stable and smaller than those observed
in the less selective PS containing membranes.
Similar conclusion can also be reached based on the kinetic mea-
surement of the CTX A3-induced membrane leakage of 6-CF probe
(Fig. 1A and B), showing that CTX A3 is more potent in inducing vesicle
leakage in sulfatide containing vesicle. For instance, at 20% leakage of
the 6-CF trapped in POPS-containing vesicles, 200 nM CTX A3 was re-
quired. But, about one-tenth the concentration of CTX A3 can generate
a similar effect on sulfatide-containing vesicles. Under these conditions,0 50 100 150 200 250
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Fig. 1. Fluorescence spectroscopic investigation on the kinetics of membrane pore
forming activities as monitored by the CTX A3-induced leakage of 6-CF probe in one
to one molar ratio of (A) POPS- or (B) sulfatide-containing POPC membrane vesicles:
The initial rate (left y-axis) and total amount (right y-axis) of membrane leakage of
6-CF in LUV (10 μM) were studied at 25 °C and plotted against the designated CTX
A3 concentrations. While the initial leakage rates increase as a square of CTX concen-
tration, the total amount of leakage depends linearly on the CTX amount added to
the vesicles. (C) At higher CTX concentration, the time required to induce leakage of
50% 6-CF probe from POPS-( ) or sulfatide-(◆) containing vesicles becomes shorter.the initial rate for CTX A3-induced leakage was ~80%/min and 25%/min
for POPS- and sulfatide-containing vesicles, respectively. Thus, the fas-
ter initial leakage rate of the POPS containing vesicles, an indication of
a larger size of CTX A3 pore, is also observed to exhibit a shorter time re-
quired to achieve 50% leakage of the vesicle content (Fig. 1C). The half-
time required for the leakage process decreases as the concentration of
CTX A3 increases, suggesting that the reaction order of leakage was
higher than one.
It is noted that, in the studied CTX A3 concentration from nM to
sub-μM range, the initial rate of CTX A3-induced vesicle leakage in-
creased as the square of CTX A3 concentration on both POPS and sul-
fatide containing vesicles. In contrast, the percentage of ﬁnal vesicular
leakage depended only linearly on CTX A3 concentration. Therefore,
under the studied experimental condition, the bimolecular interac-
tion of CTX A3 was involved in the process of pore formation and
the percentage of leakage was proportional to the number of pores.
3.2. Kinetics of CTX oligomerization as reﬂected by the kinetics of ﬂuorescence
resonance energy transfer of CTX
In order to see how the detected CTX A3 pore formation is related
to the oligomerization process of CTX A3 on the studied membrane
vesicles, we measure the ﬂuorescence resonance energy transfer be-
tween identical probes (homo-FRET) for CTX A3 labeled with rhoda-
mine, i.e., Rh-A3. Fig. 2A and B shows the dose-dependent homo-FRET
of Rh-A3 by monitoring its ﬂuorescence intensity decay as a function
of time in POPS and sulfatide-containing vesicles, respectively. When
1.25 nM of Rh-A3 was added into the POPS-containing vesicles, the
degree of CTX oligomerization can be seen to increase as reﬂected
by the ﬂuorescence intensity decay to indicate an increase of its
homo-FRET as a function of time. In consistent with this interpreta-
tion, as the concentrations of Rh-A3 increase to 100 nM, the time re-
quired for the ﬂuorescence energy decays by 50%, i.e., t1/2, for Rh-A3
on POPS-containing vesicles also decreases to ~2 s (Fig. 2C). Appar-
ently, the t1/2 required for CTX oligomerization is much shorter than
the time required for observing CTX-induced leakage of 50% 6-CF
probe, i.e., 30 s at the studied concentration of 100 nM (see Fig. 1C).
It suggests that CTX oligomerization detected by the homo-FRET
method is not a rate limiting process for the CTX pore formation on
POPS containing vesicles.
When similar experiments are performed on sulfatide containing
vesicles, we were surprised to ﬁnd that, while the ﬂuorescence inten-
sities of Rh-A3 also decayed as a function of time, there was no signiﬁ-
cant concentration dependent effect within the studied concentration
range between 1.25 nMand 100 nM (Fig. 2B). The t1/2 remains constant
(~240 s) throughout the studied concentration range (Fig. 2C) and
appeared to be longer than the time required for 50% leakage of
sulfatide-containing vesicles, i.e. ~70 s or less for CTX concentration
lower than 100 nM. Apparently, most of the CTX oligomerization as
reﬂected by the kinetics of homo-FRET is not related to the CTX A3
pore formation to account for the observed membrane leakage process.
One of the possible explanations is that effective pore formation occurs
much earlier than the CTX oligomerization detected by this homo-FRET
method and/or only a small amount of CTX oligomerization could form
effective pore in sulfatide containing vesicles. The slow kinetics of Rh-
A3 homo-FRET further suggests that, upon adding to the sulfatide con-
taining vesicles, most CTX A3 might bind at a diffusion-limited area
such as the gel phase of sulfatide lipid domain.
3.3. CTX A3 binding at sulfatide lipid domains in sulfatide containing
POPC vesicles
We determine the CTX A3 binding domain by using ﬂuorescence
imaging microscopy on supported lipid bilayers (Fig. 3). Sulfatide-
containing vesicles were fused onto glass to form a single supported
bilayer and then doped with DiIC18 (green color in Fig. 3A) to allow
0 25 50 75 100
0
30
60
240
t 1/
2 
(se
co
nd
s)
Rh-A3 (nM)
0 100 200 300
0.0
0.2
0.4
0.6
0.8
1.0
Fl
u.
 In
t./
 R
h-
A3
5 nM
30 nM
100 nM
1.25 nM
Time (second)
0 300 600 900 1200
0.0
0.2
0.4
0.6
0.8
1.0
Time (seconds)
Fl
u.
 In
t./
 R
h-
A3
1.25~100 nM
A
B
C
Fig. 2. The kinetics of oligomerization using homo-FRET assays. The ﬂuorescence intensity
decay as function of time after different concentrations of Rh-A3 is added to (A) 50% POPS-
containing vesicles or (B) 50% sulfatide-containing vesicles. The concentrations of vesicles
are 10 μM. The leakage experiments were performed at 25 °C. (C) The time (t1/2) required
for decay of half of the ﬂuorescence intensity as a function of Rh-A3 concentration in 50%
POPS ( ) or 50% sulfatide (◆) containing vesicles.
A B
C D
Fig. 3. Theﬂuorescencemicroscopic images of CTXA3 binding to supported bilayers. (A) The
supported bilayers composed of 50% sulfatidemembranes (sulfatide/POPC=1:1 inmolar ra-
tion) were dopedwith 1/500 DiIC18 (green), a ﬂuorescence probe identiﬁed by FRAP exper-
iments as a tracer for the liquid disordered (ld) phase. (B) The ﬂuorescence image of
Rhodamine labeled CTX A3 (Rh-A3) bound to supported bilayers. Rh-A3 (50 nM) was
added to the water phase of the membrane at 3 min. (C) Superposition of the two images
from A and B, showing a complementary pattern of the area for the CTX A3 binding region
and lipid ld phase region. (D) Enlarged image of panel C, showing the tubule-like structure
of sulfatide lipid domain in 50% sulfatide/POPC dispersions.
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shown in Fig. 3C, the red color area responsible for the Rh-A3 binding
to sulfatide containing membranes exhibits almost perfect comple-
mentary to the green color area responsible for the DiIC18 partition-
ing ld phase (Fig. 3). The mutual exclusive binding of the two
ﬂuorescence probes of DiIC18 and Rh-A3 was tested by the statistic
analysis of Pearson coefﬁcient [41]. Pearson's coefﬁcient was found
to be negative (−0.15), suggesting strongly that most Rh-A3 indeed
bind to lipid domains outside the DiIC18 partitioning ld phase. Al-
though this observation is consistent with the conjecture that Rh-A3
binds to gel-state sulfatide domain to account for the unexpected
large t1/2 on sulfatide containing membranes, it is not clear how
such a binding could lead to the more effective CTX A3 pore formation
responsible for the CTX-induced membrane leakage of the sulfatide
containing vesicles.3.4. Phase diagram of sulfatide containing membranes and its relationship
with CTX-induced leakage activity
To correlate the enhanced activity of CTX A3-induced leakage and
domain formation on sulfatide containing vesicles, we used DPH mole-
cules as an anisotropy probe for steady-state ﬂuorescence to determinethe phase diagram of sulfatide containing POPC dispersions. Fig. 4A
shows the representative anisotropy values of the DPH molecule,
br>DPH, as a function of temperature on sulfatide/POPC mixtures with
the designated lipid compositions. Pure (100%) POPCdispersions exhib-
it br>DPH values below 0.14, suggesting the existence of a ld phase for
100% POPC within the studied temperature range from 10 °C to 60 °C.
This is consistent with the notion that the Tm of POPC is lower than
0 °C. In contrast, sulfatide dispersions exhibit br>DPH values higher
than 0.28 within the temperature range from 10 °C to 40 °C, suggesting
the existence of so phase in the studied temperature range. The Tm of
sulfatides can then be conveniently determined by using the midpoint
of the anisotropy transition, occurring at ~45 °C for this particular sulfa-
tide sample. It should be noted that the studied sulfatides were puriﬁed
from porcine brain and contain both hydroxylated and nonhydroxy-
lated fatty acids with diverse fatty acid chain lengths. Similar results
have been reported previously by DSC and anisotropy methods [42].
The br>DPH proﬁles of the 50% sulfatide sample showed a lower
Tm with a broader interval of phase boundary as compared with
100% sulfatide (Fig. 4A and B). As we will show later, temperature de-
pendent studies on the CTX A3-induced leakage of 50% sulfatide con-
taining vesicles could be correlated with the lipid phase separation as
detected by this ﬂuorescence anisotropy method (Fig. 4B). Neither
pure ld phase nor pure so phase can provide suitable environment
for the CTX A3-induced pore formation process. This is consistent
with the previous observation that melittins cause the surface of vesi-
cles to become blurred and also induce dynamic pore formation at the
gel-to-liquid crystalline phase transition temperatures [8].
Finally, the efﬁciency of CTX-induced leakage was also studied as a
function of sulfatide concentration in POPC vesicles at 25 °C (Fig. 4C).
The CTX-induced leakage becomes most effective when 40% to 50%
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tivity could already be observed with the presence of ~10% sulfatide.
This corresponds nicely with the phase boundary between ld/so and
so phase at the studied temperature of 25 °C (see dashed line in
Fig. 4B). These results support our hypothesis that the maximum
leakage activities lie close to the boundary of the phase diagram.
3.5. Temperature dependent CTX-induced leakage of sulfatide containing
vesicles
With the availability of phase diagram for sulfatide/POPC mixtures,
it is interesting to see whether the effect of temperature on the change
of lipid phase and thus its related lipid domain could exhibit similar ef-
fect on CTX pore forming activity. As shown in Fig. 5A, CTX-induced
leakage of sulfatide containing POPC vesicles gradually increased
when temperatures decreased from 40 °C with maximum leakage ac-
tivity occurred at ~17 °C. No such temperature dependent behavior
can be detected for POPS containing POPC vesicles. Since other CTXanalogs also exhibit similar temperature dependent leakage proﬁles as
CTX A3 (data not shown), we conclude that, in addition to the lipid
binding speciﬁcity of CTXs, lipid phase domain also play an important
role in promoting CTX pore formation. It should be emphasized that
the CTX-induced membrane leakage does not depend on the tempera-
ture effect on the intrinsic stability of vesicles. At room temperature of
25 °C, there is no signiﬁcant leakage of the vesicle content up to
6 days. In contrast, the vesicles become unstable at 50 °C as evidenced
by the spontaneous leakage of 50% sulfatide containing POPC vesicles
(Fig. 5B).
We have previously shown by a combined monolayer, FTIR and
computer simulation approach that the electrostatic interaction be-
tween anionic lipid and cationic CTXs plays a role in modulating the
penetration depth of CTX molecules on the initial peripheral binding
mode and reveals a pathway leading to the formation of an inserted
mode in negatively charged membrane bilayers [26]. It is therefore
possible that a temperature dependent penetration depth of CTX on
sulfatide containing membranes could also explain, at least partially,
on the temperature dependence of the CTX-induced membrane leak-
age as observed in Fig. 5A. In order to investigate such a possibility,
we applied monolayer experiment on the binding of CTX A3 on sulfa-
tide monolayer as a function of temperature (Fig. 5C). When the
A
a b
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relevant to the biological membrane packing density, CTX A3 indeed
can insert into the negatively charged monolayer and create an
8 mN/m increase in surface pressure (Fig. 5C). As we demonstrated
previously, CTX A3 did not cause any pressure changes for the 100%
POPC monolayer at 30 mN/m initial pressure. This is consistent with
the observation that CTX A3 is not unable to form pores on POPC vesi-
cles [31]. However, there is no signiﬁcant difference for the experiments
performed on sulfatide monolayer at three different temperatures of
25 °C, 37 °C and 45 °C. In fact, similar surface expansion can also be ob-
served for the binding of CTX A3 on POPS monolayer at 25 °C (Fig. 5C).
These results indicate that the enhanced penetration depth of CTX bind-
ing to the negatively charged membranes could not explain the ob-
served temperature-dependence of CTX-induced leakage of sulfatide
containing membranes. Sulfatide lipid domains by itself indeed play
an important role in modulating CTX A3 pore formation in sulfatide
containing POPC membranes.a b c d
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Fig. 6. (A) AFM images of (a) 50% POPS/POPC (b) 40% sulfatide/POPC (c) 50% sulfatide/
POPC, and (d) 50% sulfatide/25%POPC/25% cholesterol supported bilayers. The image
size is 5 μm2 and the z-scale is 50 nm. For each image, a section analysis along the horizon-
tal line in the image is shown below the image. (B) Correlation of CTX A3-induced leakage
of 6-CF containing vesicles with the phase boundary of sulfatide lipid domains.3.6. Atomic force microscopic investigation on the sulfatide lipid domains
We have so far established that the phase boundary in the sulfa-
tide lipid domain of sulfatide/POPC dispersions plays a role in further
modulating CTX pore formation, in addition to the molecular interac-
tion observed previously between CTX A3 and sulfatide molecule. In
order to explore more on the possible role of sulfatide lipid domains
in promoting CTX A3 pore formation, we used AFM to image the sup-
ported sulfatide/POPC bilayer in the presence and absence of choles-
terol. Cholesterol has been shown to play an important role in
modulating sphingolipid domains in model membranes and is sug-
gested to be rich in biological lipid rafts [43]. As visualized by AFM,
the POPS/POPC bilayers appear to be uniformly ﬂat in the liquid
phase with only occasional small dots of debris on the surface
(panel a in Fig. 6A). This is because the Tm of POPC (−2 °C) and
POPS (14 °C) is lower than room temperature. In contrast, POPC
membrane bilayers containing 40% (panel b) and 50% sulfatide
(panel c) clearly showed a phase separation with quantitative differ-
ence in the height of distinct lipid domain. The sulfatide lipid domains
for 40% sulfatide/POPC sample exhibit a circular shape with a domain
size to be ~50–400 nm in width. It is about 15 Å higher than the sur-
rounding phase as expected from the longer hydrocarbon chain of
sulfatide molecules.
More interestingly, as demonstrated in ﬂuorescence imaging mi-
croscopic study of sulfatide containing POPC membranes (Fig. 3D),
the domain morphology of 50% sulfatide/POPC membranes exhibits
a more elongated network domain with ~200–400 nm in width (see
panel c in Fig. 6A). There are signiﬁcant differences in morphologies
between 40% and 50% sulfatide containing samples despite of their
similarity in the height difference of lipid domains (see panels b and
c in Fig. 6A). The relative areas covered by the sulfatide domains
were estimated to account for ~50% of the total area from the 50% sul-
fatide sample. In contrast, the area accountable for the sulfatide do-
mains with higher membrane surface is much less than it is
expected from the 40% sulfatide sample. It suggests that there must
be signiﬁcant miscibility of sulfatide in the ﬂuid POPC phase for 40%
sulfatide/POPC dispersions. It explains, at partially, the sharp increase
in CTX-induced membrane leakage from 40% to 50% sulfatide contain-
ing POPC vesicles.
Finally, as shown in panel d of Fig. 6A, the introduction of 25% cho-
lesterol into 50% sulfatide/POPC membrane signiﬁcantly change both
shape and height of the sulfatide lipid domain. Since the presence of
cholesterol also signiﬁcantly inhibit CTX-induced membrane leakage
by ~6-folds (compare column c with column d in Fig. 6B), we con-
clude that sulfatide lipid domains can signiﬁcantly modulate the
pore forming activity of sulfatide binding CTX A3 on sulfatide contain-
ing phosphatidylcholine membranes.4. Discussion
Biological activities of membrane-related processes such as the
pore formation of toxins [44], the open and close of ion channels
[45], the membrane curvature generation [46–48] and receptor-
mediated cell signaling [49] have now been established to involve
both hydrophobic and electrostatic interactions between proteins
and lipids. Interestingly, the physical interactions underlying these
membranes processes often require multi-valency bindings of proteins
to membrane lipid domains through a protein-clustering and/or lipid-
mediated mechanism [50]. In this study, several spectroscopic and im-
aging techniques were used to show that effective pore formation of
CTX A3, although require a pre-formed sulfatide lipid domain for its
high speciﬁcity and high afﬁnity binding, could only occur in sulfatide
containing POPC dispersions when there exist so and so/ld coexistence
1384 P.-L. Wu et al. / Biochimica et Biophysica Acta 1818 (2012) 1378–1385phase of sulfatide lipid domains. Protein binding and oligomerizations
on the bilayer surface, as reﬂected by the kinetics of CTX A3 homo-
FRET measurement, are not the rate-limiting process. Most of the CTX
A3 molecules are bound on sulfatide-containing so domain (Fig. 3)
and can only slowly oligomerize due to the slow diffusion of so domain.
Based on our previous studies, about 8 molecules of CTX A3 can form a
pore and induced all-or-none leakage on vesicles [51]. A 100 nm diame-
ter LUV is composed of about 105 lipids and 200 CTX A3 molecules are
needed for 20% leakage of sulfatide-containing vesicles. This implies
that the oligomerizations of most CTX A3molecules on membrane sur-
face are not effective to form pore. Since the pore forming activity ap-
pears to correlate well with the presence of phase boundary of
sulfatide lipid domains (Fig. 6), we hypothesize that the exposure of
the hydrophobic region in the mismatch boundary sites between dis-
tinct lipid phase domain may play an important role to facilitate the
penetration of CTX A3 into lipid bilayers to form correct membrane
oligomerization and pores.
Three lines of evidence are consistent with the hypothesis. First, by
the combined 31P and 2H NMR investigation, in conjunction with DPH
ﬂuorescence anisotropy and DSC studies, on the interaction of CTX A3
with zwitterionic dipalmitoyl PC (DPPC) dispersion, we showed that
CTX A3may penetrate and lyse the DPPC bilayers into small aggregates
at a lipid/protein molar ratio of ~20 in the ripple Pβ′ phase [52]. This
suggests that CTX A3 may undergo a re-distribution between penetra-
tion and peripheral binding states depending on the presence of distinct
lipid phase coexistence. Second, by using the single molecule ﬂuores-
cence imaging method, we have shown that amphiphilic proteins
such as cobra phospholipase A2may preferentially bind to the packing
defect regions of lipid bilayers to facilitate its enzymatic action on
the PC molecules. The phase boundary of distinct lipid phase do-
mains, such as the sulfatide lipid domains in sulfatide/POPC disper-
sions, allows the exposure of the mismatched hydrophobic region
and therefore may serve as a packing defect region to facilitate the
binding and penetration of amphiphilic CTX A3 molecules. Finally,
as we demonstrated in this work, the CTX A3-induced vesicle leak-
age of sulfatide/POPC dispersions correlates well with the phase
boundary of distinct lipid domains.
Many evidences suggest the existence of bilayer packing defect in
biological membrane surfaces due to the hydrophobic mismatch of
membrane proteins with lipid bilayers and also between distinct
lipid domains. Cholesterol in eukaryotic cell membranes has been
proposed to play a role to modulate bilayer thickness and its related
biological functions. Speciﬁcally, variation of cholesterol concentra-
tion in the glycosphingolipid raft domain has been shown to either
positively or negatively regulate biological activities of membrane
proteins. Herein, we showed that the introduction of cholesterol
into the sulfatide lipid domains inhibits CTX A3-induced membrane
leakage of sulfatide/POPC dispersions (Fig. 6). This observation is con-
sistent with the fact that depriving cholesterol molecules from the
plasma membrane of cardiomyocytes could also enhance CTX
A3-induced membrane leakage and CTX A3 internalization.
Phospholipase A2 and CTXs are the two major components of
cobra venoms and have been suggested to act synergistically for the
respective cytotoxicity on many cells. Interestingly, the presence of
lipid domains has been shown recently to induce speciﬁcity in the hy-
drolytic activity of phospholipase A2, resulting in marked differences
in the physical properties of the membrane end-product [11]. Thus,
the involvement of lipid domains in both the enzymatic activity of
phospholipase A2 and CTX A3-induced membrane leakage leads to a
new possibility that the synergistic action between cobra phospholi-
pase A2 and CTXs may also be modulated by the presence of lipid
domains.
It should be pointed out that other lipid components may also be
involved in the cytotoxicity of CTXs. For instance, it was reported re-
cently that the leakage ability in PS-containing membranes induced
by CTX from Naja kaouthia was much more pronounced than thosemeasured for the anionic lipid of sulfatide [53]. Since there are more
than seven CTX homologues in Taiwan cobra venom, understanding
the combinatorial action of CTX homologues against a distinct type
of lipid domains may be needed to fully appreciate the action mecha-
nism of cobra venoms against different cell types. Considering the di-
verse types of molecules in the plasma membranes and extracellular
matrix have now been shown to be a potential target of CTX action
[20], future investigation to understand how snake venomworks ondif-
ferent cell typesmay help to establishmethods for the understanding of
the biological functions in the newly established proteomic world.Acknowledgements
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